133 related articles for article (PubMed ID: 9151155)
1. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
Kojima S; Yoshitomi Y; Sugi T; Matsumoto Y; Yano M; Kuramochi M
Ther Apher; 1998 Nov; 2(4):263-7. PubMed ID: 10227752
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
[TBL] [Abstract][Full Text] [Related]
4. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column.
Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503
[TBL] [Abstract][Full Text] [Related]
5. Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
Kojima S; Shiba M; Kuramochi M; Yamamoto A
Artif Organs; 1995 Feb; 19(2):135-9. PubMed ID: 7763192
[TBL] [Abstract][Full Text] [Related]
6. Contact activation in low-density lipoprotein apheresis systems.
Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
[TBL] [Abstract][Full Text] [Related]
7. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
[TBL] [Abstract][Full Text] [Related]
8. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Kizaki Y; Ueki Y; Yoshida K; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):341-9. PubMed ID: 10493215
[TBL] [Abstract][Full Text] [Related]
9. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.
Koga N; Nagano T; Sato T; Kagasawa K
ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan on low-density lipoprotein apheresis.
Kojima S; Yoshitomi Y; Saotome M; Tanaka K; Shida M; Kuramochi M
Ther Apher; 1999 Nov; 3(4):303-6. PubMed ID: 10608722
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
[TBL] [Abstract][Full Text] [Related]
12. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
Koga N
Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
[TBL] [Abstract][Full Text] [Related]
14. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems.
Knisel W; Di Nicuolo A; Pfohl M; Müller H; Risler T; Eggstein M; Seifried E
J Intern Med; 1993 Nov; 234(5):479-87. PubMed ID: 8228792
[TBL] [Abstract][Full Text] [Related]
15. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis and changes in plasma components.
Kojima S
Ther Apher; 2001 Aug; 5(4):232-8. PubMed ID: 11724506
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.
Handschel D; Etienne Janssens M; Gericke M; De Reys S; Borberg H
J Clin Apher; 2017 Oct; 32(5):319-328. PubMed ID: 27676234
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
[TBL] [Abstract][Full Text] [Related]
19. Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis.
Pintus S; Pintus P; Piras C; Loviselli A; Muntoni S
J Clin Apher; 1994; 9(2):124-5. PubMed ID: 7798159
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
Moriarty P; Sosland R; Gibson C; Belmont J
Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
